Litigation

Recent Posts

Jury Awards $9B In 1st MDL Actos Bladder Cancer Trial Against Takeda, Eli Lilly
Posted on 8 Apr 2014 by Tom Moylan

LAFAYETTE, La. — (Mealey’s) The first federal court Actos bladder cancer trial ended April 7 in a $9 billion verdict against co-defendants Takeda Pharmaceuticals USA Inc. and Eli Lilly & Co. Inc., according to Takeda ( In Re: Actos [Pioglitazone... Read More

Tags: drugs , (In Re: Actos [Pioglitazone] Products Liability Litigation , et al. , Actos , Terrence and Susan Allen , bladder cancer , MDL Docket No. 2299 , Louisiana , Litigation , multidistrict litigation , Eli Lilly & Co. Inc. , Takeda Pharmaceuticals USA Inc. , verdict , Allen v. Takeda Pharmaceuticals North America Inc.